As the first cracks appear in the pan-European prohibitionary edifice, Germany is about to embark on a legalisation journey of seismic proportions and far-reaching ripple effects. Euromonitor International forecasts overall cannabis sales in Germany (including medical, recreational and CBD) to reach EUR2.5 billion by 2026, with the actual sales timeline for adult use projected to be rolled out around mid-2024. And that is where projections get hazier than the atmosphere in a Californian cannabis lounge. The 1961 UN Single Convention on Narcotic Drugs prohibits Germany from legalising recreational cannabis, as it bans states from cultivating and trafficking outside of medical or scientific purposes. Demographic breakdowns, branding exercises, insights on need states and consumption occasions, promotional and outreach activities and product formulation have all been glaringly missing in the ongoing debates.

Source: The North Africa Journal July 08, 2022 08:04 UTC